Laura E. MacConaill

26.7k total citations · 3 hit papers
91 papers, 8.0k citations indexed

About

Laura E. MacConaill is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Laura E. MacConaill has authored 91 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 36 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Laura E. MacConaill's work include Cancer Genomics and Diagnostics (34 papers), Lung Cancer Treatments and Mutations (13 papers) and Melanoma and MAPK Pathways (8 papers). Laura E. MacConaill is often cited by papers focused on Cancer Genomics and Diagnostics (34 papers), Lung Cancer Treatments and Mutations (13 papers) and Melanoma and MAPK Pathways (8 papers). Laura E. MacConaill collaborates with scholars based in United States, South Korea and Canada. Laura E. MacConaill's co-authors include Levi A. Garraway, William C. Hahn, Matthew Meyerson, Sarah M. Kehoe, Paul Van Hummelen, Matthew D. Ducar, Neal I. Lindeman, Frank C. Kuo, Nikhil Wagle and Panisa Pochanard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Laura E. MacConaill

88 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent BRAF mutations in Langerhans cell histiocytosis

2010 742 citations Gayane Badalian‐Very, Jo‐Anne Vergilio et al. Blood profile →
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling

2011 732 citations Nikhil Wagle, Michael F. Berger et al. Journal of Clinical Oncology profile →
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

2013 419 citations Priscilla K. Brastianos, Peleg Horowitz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura E. MacConaill United States	44	3.6k	2.7k	1.7k	1.6k	1.3k	91	8.0k
Peter B. Illei United States	48	2.7k 0.7×	2.7k 1.0×	1.4k 0.8×	3.9k 2.4×	688 0.5×	151	8.3k
Bruce A. Woda United States	49	2.8k 0.8×	2.3k 0.9×	1.2k 0.7×	1.8k 1.1×	1.9k 1.5×	181	9.1k
Peter Vandenberghe Belgium	58	3.1k 0.8×	2.2k 0.8×	1.0k 0.6×	1.5k 0.9×	2.4k 1.8×	229	10.7k
David E. Wazer United States	51	2.2k 0.6×	2.6k 1.0×	3.8k 2.3×	1.2k 0.7×	2.1k 1.6×	266	8.6k
Raymond R. Tubbs United States	59	2.7k 0.7×	4.7k 1.8×	1.4k 0.9×	2.3k 1.4×	2.6k 2.0×	276	10.8k
Ruth L. Katz United States	46	3.3k 0.9×	3.5k 1.3×	2.1k 1.2×	2.1k 1.3×	2.0k 1.5×	212	9.3k
Gustavo Baretton Germany	46	2.5k 0.7×	3.0k 1.1×	1.5k 0.9×	1.9k 1.1×	916 0.7×	312	7.3k
Suzanne Kamel‐Reid Canada	55	4.4k 1.2×	4.3k 1.6×	3.0k 1.8×	3.6k 2.2×	1.3k 1.0×	285	12.1k
Christopher D. Gocke United States	39	2.2k 0.6×	2.0k 0.8×	1.6k 0.9×	1.2k 0.7×	1.2k 0.9×	185	5.8k
Thomas J. FitzGerald United States	44	1.5k 0.4×	1.1k 0.4×	909 0.5×	1.5k 0.9×	711 0.5×	285	6.7k

Countries citing papers authored by Laura E. MacConaill

Since Specialization

Citations

This map shows the geographic impact of Laura E. MacConaill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. MacConaill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. MacConaill more than expected).

Fields of papers citing papers by Laura E. MacConaill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. MacConaill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. MacConaill. The network helps show where Laura E. MacConaill may publish in the future.

Co-authorship network of co-authors of Laura E. MacConaill

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. MacConaill. A scholar is included among the top collaborators of Laura E. MacConaill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. MacConaill. Laura E. MacConaill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dennis, Michael J., Dean C. Pavlick, Alec Kacew, et al.. (2024). Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma. Journal of Translational Medicine. 22(1). 960–960. 2 indexed citations

Gupta, Hersh, Rachel A. Freedman, Melissa E. Hughes, et al.. (2023). Abstract P5-14-06: Tumor Genomic Landscape in Older Women with Metastatic Breast Cancer (MBC). Cancer Research. 83(5_Supplement). P5–14.

Russell‐Goldman, Eleanor, Laura E. MacConaill, Alvaro C. Laga, & John Hanna. (2023). Deep‐penetrating‐nevus‐like melanoma arising in patients with familial adenomatous polyposis syndrome. Journal of Cutaneous Pathology. 50(9). 801–805. 2 indexed citations

Gomy, Israel, Alexander Gusev, Bruce E. Johnson, et al.. (2021). Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing. JCO Precision Oncology. 5(5). 1749–1757. 9 indexed citations

Slevin, Michael K., Bruce M. Wollison, Robert T. Burns, et al.. (2020). ViroPanel. Journal of Molecular Diagnostics. 22(4). 476–487. 3 indexed citations

Russell‐Goldman, Eleanor, Laura E. MacConaill, & John Hanna. (2020). Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma. American Journal of Dermatopathology. 43(4). 266–272. 9 indexed citations

Mirković, Jelena, Fei Dong, Lynette M. Sholl, et al.. (2018). Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO). International Journal of Gynecological Pathology. 38(6). 543–551. 25 indexed citations

Bi, Wenya Linda, Peleg Horowitz, Noah F. Greenwald, et al.. (2016). Landscape of Genomic Alterations in Pituitary Adenomas. Clinical Cancer Research. 23(7). 1841–1851. 88 indexed citations

Mirković, Jelena, Lynette M. Sholl, Elizabeth Garcia, et al.. (2015). Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Modern Pathology. 28(11). 1504–1514. 101 indexed citations

10.

Brown, Jennifer R., Megan Hanna, Bethany Tesar, et al.. (2012). Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 18(14). 3791–3802. 59 indexed citations

11.

Daniels, Anthony B., Jooeun Lee, Laura E. MacConaill, et al.. (2012). High Throughput Mass Spectrometry-Based Mutation Profiling of Primary Uveal Melanoma. Investigative Ophthalmology & Visual Science. 53(11). 6991–6991. 37 indexed citations

12.

Hanna, Megan, Bethany Tesar, Lillian Werner, et al.. (2012). Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia. DSpace@MIT (Massachusetts Institute of Technology). 3 indexed citations

13.

Wagle, Nikhil, Michael F. Berger, Matthew J. Davis, et al.. (2011). Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling. Journal of Clinical Oncology. 29(22). 3085–3096. 732 indexed citations breakdown →

14.

Wagle, Nikhil, Michael F. Berger, Matthew J. Davis, et al.. (2011). High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing. Cancer Discovery. 2(1). 82–93. 384 indexed citations

15.

Oberholzer, Patrick A., Damien Kee, Piotr Dziunycz, et al.. (2011). RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors. Journal of Clinical Oncology. 30(3). 316–321. 298 indexed citations

16.

Rich, Benjamin E., Natalie Vena, Justin M. Craig, et al.. (2011). Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pediatric Low-Grade Gliomas. Journal of Molecular Diagnostics. 13(6). 669–677. 64 indexed citations

17.

Qin, Wei, Vineeta Bajaj, Izabela A. Malinowska, et al.. (2011). Angiomyolipoma Have Common Mutations in TSC2 but No Other Common Genetic Events. PLoS ONE. 6(9). e24919–e24919. 48 indexed citations

18.

Badalian‐Very, Gayane, Jo‐Anne Vergilio, Barbara Degar, et al.. (2010). Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 116(11). 1919–1923. 742 indexed citations breakdown →

19.

Miron, Alexander, Mária Váradi, Daniel R. Carrasco, et al.. (2010). PIK3CA Mutations in In situ and Invasive Breast Carcinomas. Cancer Research. 70(14). 5674–5678. 107 indexed citations

20.

Nikolsky, Yuri, Jun Yao, Damir Dosymbekov, et al.. (2008). Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer. Cancer Research. 68(22). 9532–9540. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact